04936nam a2200397za 
45000010014000000030008000140050017000220070015000390080041000540200028000950200025001230220014001480400026001620720016001880720
01500204072001500219245009000234260005400324365011000378366003500488490003600523500004700559505105600606516001301662520116901675
54513600284465000340420465000330423865000330427170000330430470000230433770000200436070000200438085600720440085600660447297818
49841009UK-WkNB20181129000000.0cu||||||||||||181129e201811uuxxk    |s|||||||0|0 eng|d  a9781849841009 
:c$85.00  a1849841004 :c$85.00  a2312-5098  aUK-WkNBbengcUK-WkNB 7aMJL2bicssc 
7aHEA2ukslc 7aMJL2thema10aTuberculosish[electronic resource] /cEdited by Giovanni Battista Migliori [et 
al.].  aSheffield :bEuropean Respiratory Society,c2018.  a02b85.00cUSDd00eThis price includes a tax 
elementhZ 85.00 0.00 85.00 0.00jGBkxxkmTEDITOR2onix-pt  b20181129cIPjGBkxxk2UK-WkNB0 aERS 
Monograph,x2312-5098 ;v82  aElectronic book text. Text (eye-readable).0 aThe patients' perspective-- History of 
tuberculosis-- Epidemiology and socioeconomic determinants-- Evolution of the strategies for control and elimination-- 
Aetiopathogenesis, immunology and microbiology-- Clinical diagnosis-- Laboratory diagnosis-- Imaging for diagnosis and 
management-- Bronchoscopy and other invasive procedures for diagnosis-- Treatment of drug-susceptible and drug-resistant 
tuberculosis-- New and repurposed drugs-- Adverse anti-tuberculosis drug events and their management-- Surgery as a 
treatment-- Challenges in childhood tuberculosis-- Pregnancy and the elderly-- Comorbidities-- Access and adherence to 
prevention and care for hard-to-reach groups-- Monitoring during and after treatment-- Sequelae assessment and 
rehabilitation-- Towards a new vaccine-- Transmission control: a refocused approach-- Diagnosis and treatment of latent 
tuberculosis infection-- Nontuberculous mycobacteria-- What next? Basic research, new treatments and a patient-centred 
approach-- Opportunities for training and learning-- Clinical cases.  aDocument  aThis book brings together chapters 
from global experts and begins with a patients' perspective. Chapters that follow cover: the history of TB; epidemiology; 
strategies for control and elimination; clinical and laboratory diagnosis; imaging; treatment and drugs; TB in children and 
different patient populations; comorbidities; clinical cases.bWith over 10 million new TB cases and 1.6 million deaths, TB 
is a global health priority. Multidrug-resistant TB is of particular concern to both clinicians and national TB programmes: in 
2017, there were 558 000 new rifampicin-resistant cases and 460 000 confirmed multidrug-resistant TB cases. Despite extensive 
investigation over the years, there is still a great deal to learn about the prevention, diagnosis and treatment of TB. This 
Monograph brings together chapters from global TB experts and begins with a patients' perspective that sets the tone. The 
following chapters cover: the history of TB; epidemiology; strategies for control and elimination; clinical and laboratory 
diagnosis; imaging; treatment and drugs; TB in children and different patient populations; comorbidities; clinical cases; and 
much more.0 aGiovanni Battista Migliori is a specialist in respiratory medicine and medical statistics, and an auditor of 
quality systems. He has over 20 years of experience in design, implementation, and monitoring and evaluation of TB and TB/HIV 
control programmes globally. Giovanni Battista Migliori is Head of Clinical Epidemiology of the Respiratory Disease Service 
and Director of the WHO Collaborating Centre for TB and Lung Disease at Maugeri Care and Research Institute (Tradate, Italy). 
Graham Bothamley has been a respiratory physician for 35 years and has looked after over 4000 patients with TB. He is 
currently a member of the TB Centre and Immunology and Infections Department at the London School of Hygiene and Tropical 
Medicine (London, UK) and at the Blizard Institute (Queen Mary University of London, London, UK). Raquel Duarte is the 
Coordinator of the National Reference Centre for MDR-TB, the Director of the National Programme for TB and Associate Professor 
at the Medical School and at the Institute of Public Health of Porto University (Porto, Portugal). Adrian Rendon is a 
specialist in internal medicine and pulmonary and critical care medicine. He is Professor of Medicine at the School of 
Medicine and the University Hospital of Monterrey of the Universidad Autonoma de Nuevo Leon (Mexico), where he has run a busy 
TB clinic since 1994. 7aRespiratory medicine.2bicssc 7aHealth and Wellbeing.2ukslc 7aRespiratory 
medicine.2thema1 aMigliori, Giovanni Battista.1 aBothamley, Graham.1 aDuarte, Raquel.1 aRendon, 
Adrian.4 uhttp://www.books.ersjournals.comx01zPublisher's corporate website4 
uhttp://www.ersbookshop.comx01zPublisher's corporate website